HLB innoVation

024850 · KOSDAQ · Information Technology · SMALL CAP

Updated terms.

HLB innoVation updated the disclosed terms of an acquisition of VERISMO THERAPEUTICS, INC., now worth US$26.8M.

M&A([Amended] Decision to acquire shares/equity in another company)· FILED 2026-06-25· RCEPT 20260625900497

US$26.8MDeal value
15.4%vs. company assets

Converted at 1 USD ≈ ₩1,546.48 (filing-date rate, 2026-06-25 close)

A later amendment corrects this filing, so the terms on this page may be out of date. See the latest version (2026-08-13) →

What happened

HLB innoVation updated the disclosed terms of an acquisition of VERISMO THERAPEUTICS, INC., now worth US$26.8M.

For context, this deal is worth about 15.4% of the company's own total assets.

TargetVERISMO THERAPEUTICS, INC.
Deal valueUS$26.8M
vs. company assets15.4%
Filed2026-06-25, [Amended] Decision to acquire shares/equity in another company
SourceDART rcept 20260625900497 → open original filing

Versions of this filing

  1. 2026-04-10Original
  2. 2026-06-25Amendment 1 (this page)
  3. 2026-08-13Amendment 2

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-06-25 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.